Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk ...

Elektra Health, a digital health company for women going through menopause, has secured $3.3 million in extended seed funding, which it will use to expand its care to more patients, it announced ...

In the rare disease hereditary angioedema, or HAE, painful swelling attacks can happen anywhere in the body without warning. Drugs are available for acute treatment of these attacks, but they’re all ...

In a Monday letter, a group of 350 organizations urged Congress to make Covid-19 Medicare telehealth flexibilities permanent. If Congress can’t make these flexibilities —which are set to expire in ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

Function Health, a membership-based platform that gives consumers access to more than 100 different lab tests, on Tuesday announced the close of a sizable funding round — one that includes about a ...

With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs.

An exploration of the AI companies in healthcare, the drug price debate and the latest twist in the Trump Administration’s allegation that Tylenol is linked to autism were the hot topics on the latest ...

Advanced prostate cancer has a new treatment option, a Johnson & Johnson drug that combines two of the company’s therapies in a single pill. Niraparib is small molecule designed to block PARP, an ...

For instance, AI can examine patient data to predict the likelihood of developing certain diseases and the associated trajectory of disease burden, which allows for early interventions and preventive ...

The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen. The ...

The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.